title: Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.
authors.forename: K
authors.initials: K
authors.lastname: Kakihana
authors.forename: K
authors.initials: K
authors.lastname: Ohashi
authors.forename: Y
authors.initials: Y
authors.lastname: Murata
authors.forename: M
authors.initials: M
authors.lastname: Tsubokura
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: T
authors.initials: T
authors.lastname: Yamashita
authors.forename: H
authors.initials: H
authors.lastname: Sakamaki
authors.forename: H
authors.initials: H
authors.lastname: Akiyama
mesh_terms: D000293:Adolescent; D000328:Adult; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006086:Graft vs Host Disease / Q000000981:diagnostic imaging / Q000517:prevention & control*; D019337:Hematologic Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011859:Radiography; D012189:Retrospective Studies; D013577:Syndrome; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*; D014184:Transplantation, Homologous
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus